Harnessing IgG Fc glycosylation for clinical benefit.

Archer, Eva J; Gonzalez, Joseph C; Ghosh, Debopam; Mellins, Elizabeth D; Wang, Taia T

Archer, Eva J; Gonzalez, Joseph C; Ghosh, Debopam; Mellins, Elizabeth D; Wang, Taia T.

Affiliation

Archer EJ; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Gonzalez JC; Department of Medicine, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, USA; Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Ghosh D; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA; Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Mellins ED; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA; Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Wang TT; Department of Medicine, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, USA; Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.

Curr Opin Immunol ; 77: 102231, 2022 08.

Article de En | MEDLINE | ID: mdl-35797920

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Immunoglobuline G / Récepteurs du fragment Fc des IgG Limites: Humans Langue: En Journal: Curr Opin Immunol Sujet du journal: ALERGIA E IMUNOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google